(Q34158742)

31 July 2017

1 reference

title

Parkinson's disease and related synucleinopathies are a new class of nervous system amyloidoses (English)

1 reference

31 July 2017

1 reference

1

John Q Trojanowski

1 reference

31 July 2017

Virginia M Y Lee

2

1 reference

31 July 2017

1 October 2002

1 reference

31 July 2017

1 reference

31 July 2017

23

1 reference

31 July 2017

4-5

1 reference

31 July 2017

457-460

1 reference

Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900065-7

7 January 2021

Drosophila models of human neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900065-7

7 January 2021

Synucleins in synaptic plasticity and neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900065-7

7 January 2021

Alpha-synuclein and the Lewy body disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900065-7

7 January 2021

Studying human neurodegenerative diseases in flies and worms

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900065-7

7 January 2021

A Drosophila model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900065-7

7 January 2021

Synucleinopathies: clinical and pathological implications

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900065-7

7 January 2021

Alpha-synuclein and neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900065-7

7 January 2021

beta-Synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900065-7

7 January 2021

Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900065-7

7 January 2021

Lewy Body Pathology in Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900065-7

7 January 2021

Parkinson's disease. First of two parts

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900065-7

7 January 2021

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900065-7

7 January 2021

beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900065-7

7 January 2021

Alzheimer's disease and Parkinson's disease: distinct entities or extremes of a spectrum of neurodegeneration?

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900065-7

7 January 2021

"Fatal attractions" of proteins. A comprehensive hypothetical mechanism underlying Alzheimer's disease and other neurodegenerative disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900065-7

7 January 2021

10.1016/S0161-813X(02)00065-7

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

12428717